About 1 200 reports

  • MONOCLONAL ANTIBODIES FOR RABIES - DRUG PROFILE
  • MONOCLONAL ANTIBODIES FOR RABIES - DRUG PROFILE

MONOCLONAL ANTIBODIES FOR RABIES - DRUG PROFILE MONOCLONAL ANTIBODIES TO INHIBIT GLYCOPROTEIN FOR RABIES - DRUG PROFILE MONOCLONAL ANTIBODIES TO INHIBIT GLYCOPROTEIN FOR RABIES Drug Name Company/ Institute Name Licensed From Company Developme

  • Infectious Disease
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • CureVac GmbH
  • MONOCLONAL ANTIBODIES TO INHIBIT IL-1A FOR ATHEROSCLEROSIS AND MYOCARDIAL INFARCTION - DRUG PROFILE
  • DORMANT PRODUCTS, H2 2018 (CONTD..3), H2 2018

CV-##C## IS BASED ON TRUE HUMAN ANTI-IL-## ALPHA MONOCLONAL ANTIBODY (MABP##) PLATFORM TECHNOLOGY.

  • Monoclonal Antibody
  • Therapy
  • United States
  • World
  • Product Initiative

MARKET OVERVIEW.............. ## Therapeutic Biologics.............. ## Table ##: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin,

  • Monoclonal Antibody
  • China
  • United States
  • Market Competition
  • Market Shares
  • KEYTRUDA DRUG PROFILE
  • Product profile (late stage): glembatumumab vedotin

Keytruda is a humanized monoclonal antibody designed to inhibit the PD-## co-inhibitory receptor.

  • Monoclonal Antibody
  • European Union
  • Japan
  • United States
  • TESARO, Inc.
  • MONOCLONAL ANTIBODY TO INHIBIT E1 AND E2 GLYCOPROTEIN FOR HEPATITIS C - DRUG PROFILE
  • MONOCLONAL ANTIBODIES TO INHIBIT E2 GLYCOPROTEIN FOR HCV - DRUG PROFILE

NA NA MONOCLONAL ANTIBODY TO INHIBIT E## FOR HEPATITIS C - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description LifeArc NA NA Monoclonal Antibody to Inhibit E## for Hepatitis C Monoclonal

  • Hepatitis
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative
  • MONOCLONAL ANTIBODIES TO INHIBIT TGF BETA1 FOR ONCOLOGY - DRUG PROFILE
  • MONOCLONAL ANTIBODY 1 TO INHIBIT TGFB1 FOR ONCOLOGY - DRUG PROFILE

Monoclonal antibody acts as transforming growth factor beta ## inhibitor.

  • Immunotherapy
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Sirnaomics, Inc.
  • HERCEPTIN (TRASTUZUMAB; ROCHE/CHUGAI) - DRUG PROFILE
  • PERJETA (PERTUZUMAB; GENENTECH/ROCHE/CHUGAI) - DRUG PROFILE

Perjeta is a human epidermal growth factor receptor ## (HER##)-targeted humanized monoclonal antibody.

  • Monoclonal Antibody
  • European Union
  • United States
  • GlaxoSmithKline plc
  • Roche Group
  • summarizes the drug approvals for vasculitis across the 7MM, as of December 2015.
  • HUMIRA SWOT ANALYSIS, 2015

BIOGEN/ GENENTECH/ ROCHE' S RITUXAN (RITUXIMAB), MARKETED UNDER THE BRAND NAME MABTHERA OUTSIDE OF THE US, AND IS A CHIMERIC MURINE/ HUMAN MONOCLONAL ANTIBODY (MAB) USED FOR THE TREATMENT OF PATIENTS WITH ACTIVE GPA AND MPA.

  • Monoclonal Antibody
  • Chugai Pharmaceutical Co., Ltd.
  • Mitsubishi Corporation
  • Remicade group
  • Roche Group
  • Source: GBI Research, Proprietary Marketed Product Database Abbreviations: mAb: monoclonal Antibody
  • Source: GBI Research, Proprietary Marketed Product Database Abbreviations: mAb: monoclonal Antibody

Human monoclonal antibodies against amyloid-beta from healthy adults.

  • Monoclonal Antibody
  • Therapy
  • Company
  • Company Financials
  • Forecast
  • MONOCLONAL ANTIBODY TO INHIBIT CD73 FOR NON SMALL CELL LUNG CANCER AND OVARIAN CANCER - DRUG PROFILE
  • MONOCLONAL ANTIBODY TO INHIBIT CD73 FOR NON SMALL CELL LUNG CANCER AND OVARIAN CANCER - DRUG PROFILE

Monoclonal antibody acts by inhibiting CD##.

  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Company Operations
  • Product Initiative
  • Monoclonal Antibodies for Ebola Virus Infections
  • MONOCLONAL ANTIBODIES FOR EBOLA VIRUS INFECTIONS - DRUG PROFILE

It is a monoclonal recombinant antibody.

  • Infectious Disease
  • Monoclonal Antibody
  • Vaccine
  • United States
  • Hemispherx Biopharma, Inc.
  • MONOCLONAL ANTIBODIES FOR DENGUE - DRUG PROFILE
  • MONOCLONAL ANTIBODY FOR DENGUE - DRUG PROFILE

MONOCLONAL ANTIBODIES FOR DENGUE - DRUG PROFILE MONOCLONAL ANTIBODIES FOR DENGUE NATIONAL CANCER INSTITUTE US MONOCLONAL ANTIBODIES ARE UNDER INVESTIGATION FOR THE TREATMENT OF DENGUE TYPE ##, ##, ## AND ## VIRUS INFECTIONS.

  • Drug Development
  • Monoclonal Antibody
  • World
  • Company
  • Product Initiative
  • Monoclonal Antibodies to Inhibit PCSK9 for Hypercholesterolemia
  • Monoclonal Antibody to Inhibit PCSK9 for Hypercholesterolemia

The drug candidate is a monoclonal antibody acts by targeting PCSK##.

  • Lipid Modifying Drug
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • MONOCLONAL ANTIBODY FOR ANTHRAX - DRUG PROFILE
  • MONOCLONAL ANTIBODY FOR ANTHRAX - DRUG PROFILE

NA : Not Available MARINUS - DRUG PROFILE MONOCLONAL ANTIBODY FOR ANTHRAX - DRUG PROFILE MONOCLONAL ANTIBODY FOR ANTHRAX - DRUG PROFILE MONOCLONAL ANTIBODY TO INHIBIT ANTHRAX PROTECTIVE ANTIGEN FOR ANTHRAX - DRUG PROFILE Monoclonal

  • Infectious Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • Product profile (late stage): inotuzumab ozogamicin
  • METHODS

Inotuzumab ozogamicin is a monoclonal CD## antibody conjugated to the cytotoxic agent calicheamicin.

  • Monoclonal Antibody
  • Amgen Inc.
  • ARIAD Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.
  • MONOCLONAL ANTIBODY TO INHIBIT COMPLEMENT C3 AND COMPLEMENT C5 FOR ISCHEMIA REPERFUSION INJURY - DRUG PROFILE
  • MONOCLONAL ANTIBODY TO INHIBIT COMPLEMENT C5 FOR AGE RELATED MACULAR DEGENERATION - DRUG PROFILE

IFX-## is humanized monoclonal antibody that targets complement activation product C##a.

  • Hospital
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Alexion Pharmaceuticals, Inc.
  • GE HEALTHCARE INTRODUCED A NEW PROTEIN A CHROMATOGRAPHY RESIN, MABSELECT PRISMA, FOR MONOCLONAL ANTIBODIES PURIFICATION.
  • Resin

The monoclonal antibodies market in the country has witnessed significant growth over the years.

  • Monoclonal Antibody
  • North America
  • United States
  • Forecast
  • Market Size

Infliximab is has main key components as human mouse antibody amino acids because of which is referred aschimeric monoclonal antibody.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • MONOCLONAL ANTIBODIES TO INHIBIT LECT2 FOR AMYLOIDOSIS - DRUG PROFILE
  • MONOCLONAL ANTIBODY TO TARGET CD66B FOR BLOOD CANCER AND METABOLIC DISORDERS - DRUG PROFILE

This has not previously been demonstrated with a single-agent monoclonal antibody in MM.

  • Endocrine Disease
  • Hospital
  • Monoclonal Antibody
  • Therapy
  • Alnylam Pharmaceuticals, Inc.
  • MONOCLONAL ANTIBODIES TO INHIBIT SCG3 FOR DIABETIC RETINOPATHY AND RETINOPATHY OF PREMATURITY - DRUG PROFILE
  • NUMBER OF PRODUCTS BY STAGE AND MOLECULE TYPE, H1 2018

Hoffmann-La Roche Ltd NA Genentech Inc; Novartis AG R& D Progress Research and Development Brief Ranibizumab (Lucentis) is a humanized monoclonal antibody fragment and a recombinant humanized IgO ## isotype designed to bind to and inhibit vascular endothelial growth fact

  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World
  • Insmed Incorporated
  • Monoclonal Antibody to Inhibit CFD for Glomerulonephritis
  • MONOCLONAL ANTIBODY TO INHIBIT CFD FOR GLOMERULONEPHRITIS - DRUG PROFILE

HL-## (RVT-##) is an anti-FcRn fully human monoclonal antibody.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Pharmaceutical
  • Type 2 Diabetes
  • ChemoCentryx, Inc.
  • MONOCLONAL ANTIBODIES TO AGONIZE OX40 FOR ONCOLOGY - DRUG PROFILE
  • BISPECIFIC MONOCLONAL ANTIBODIES TO AGONIZE TNFRSF4 FOR ONCOLOGY - DRUG PROFILE

Monoclonal antibodies act as OX##L (CD##) agonists.

  • Monoclonal Antibody
  • Oncology
  • United States
  • Product Initiative
  • MedImmune, LLC
  • BISPECIFIC MONOCLONAL ANTIBODY TO INHIBIT CD4 AND GP120 FOR HIV INFECTIONS - DRUG PROFILE
  • MONOCLONAL ANTIBODY CONJUGATES TO TARGET CD4 AND HDAC FOR HIV-1 - DRUG PROFILE

MONOCLONAL ANTIBODY CONJUGATES TO TARGET CD## AND HDAC FOR HIV-## - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description TaiMed Biologics Inc NA NA Monoclonal Antibody Conjugates to Target CD## and

  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • PIERIS PHARMACEUTICALS
  • STC BIOLOGICS

Pan-HER is a mixture of six humanized full length monoclonal antibodies targeting EGFR, HER## and HER##.

  • Monoclonal Antibody
  • Genentech, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Roche Group
  • Zyngenia, Inc.
  • MONOCLONAL ANTIBODY TO INHIBIT HEMAGGLUTININ FOR INFLUENZA VIRUS A INFECTIONS - DRUG PROFILE
  • MONOCLONAL ANTIBODY TO INHIBIT HEMAGGLUTININ FOR INFLUENZA VIRUS A INFECTIONS - DRUG PROFILE

It is a fully human monoclonal antibody.

  • Influenza
  • Monoclonal Antibody
  • Vaccine
  • United States
  • Product Initiative
  • Clinical Trials Apr 18, 2017: XOMA Presents Positive Data from PTH1R Monoclonal Antibody Program
  • Mar 28, 2017: XOMA to Present Preclinical Data from its PTH1R Monoclonal Antibodies Program at the American Association for Cancer Research Annual Meeting

Licensing the global commercial rights to gevokizumab, a novel anti-IL-## beta allosteric monoclonal antibody, to Novartis.

  • Immunotherapy
  • Monoclonal Antibody
  • United States
  • Company
  • XOMA Corporation
  • MONOCLONAL ANTIBODY FOR ANTHRAX - DRUG PROFILE
  • MONOCLONAL ANTIBODY FOR ANTHRAX - DRUG PROFILE

MARINUS - DRUG PROFILE MONOCLONAL ANTIBODY FOR ANTHRAX - DRUG PROFILE MONOCLONAL ANTIBODY FOR ANTHRAX - DRUG PROFILE MONOCLONAL ANTIBODY TO INHIBIT ANTHRAX PROTECTIVE ANTIGEN FOR ANTHRAX - DRUG PROFILE NASOSHIELD - DRUG PROFILE anthrax vaccine, w

  • Infectious Disease
  • Monoclonal Antibody
  • Pathology
  • Vaccine
  • Pfenex Inc.
  • MONOCLONAL ANTIBODY TO ANTAGONIZE IL-2R BETA FOR CELIAC DISEASE, ONCOLOGY AND TROPICAL SPASTIC PARAPARESIS - DRUG PROFILE
  • CALY-002 - DRUG PROFILE

It is a human monoclonal antibody targeting the cytokine IL-##.

  • Monoclonal Antibody
  • United States
  • Company
  • Company Operations
  • Product Initiative
  • MONOCLONAL ANTIBODY TO INHIBIT VEGF FOR OPHTHALMOLOGY AND ONCOLOGY - DRUG PROFILE
  • NUMBER OF PRODUCTS BY STAGE AND MOLECULE TYPE, H2 2018

It also provides monoclonal antibodies for the treatment of cancer.

  • Monoclonal Antibody
  • Ophthalmology
  • Pharmaceutical
  • United States
  • Clearside Biomedical, Inc.
  • MONOCLONAL ANTIBODY TO INHIBIT TIRC-7 FOR CARDIAC AND KIDNEY TRANSPLANTATION - DRUG PROFILE
  • NUMBER OF PRODUCTS BY STAGE AND MOLECULE TYPE, H2 2017

Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Nekonal Sarl NA NA MONOCLONAL ANTIBODY TO INHIBIT TIRC-## FOR CARDIAC AND KIDNEY TRANSPLANTATION - DRUG PROFILE Monoclonal Antibody to Inhibit TIRC-## for Cardiac and

  • Heart Transplant
  • Medical Biotechnology
  • Monoclonal Antibody
  • Transplantation
  • Astellas Pharma Inc.